Related Experiment Videos
Proteomics on its way to study host-pathogen interaction in Candida albicans
1Fraunhofer IGB, Nobelstr. 12, 70569 Stuttgart, Germany. rupp@igb.fhg.de
Current Opinion in Microbiology
|September 11, 2004
Summary
Proteomics of Candida albicans, a common human fungal pathogen, is advancing rapidly. New genomic and mass spectrometry tools enable large-scale studies of its cell wall, drug responses, and virulence factors.
Area of Science:
- Microbiology
- Biochemistry
- Proteomics
Background:
- Candida albicans is a prevalent human fungal pathogen and commensal.
- Proteomics applications for C. albicans have been limited historically.
- Recent advancements in genome sequencing and mass spectrometry have revolutionized C. albicans research.
Purpose of the Study:
- To highlight the expanding role of proteomics in understanding Candida albicans.
- To showcase emerging applications of C. albicans proteomics.
- To underscore the potential of proteomics in unraveling host-pathogen interactions.
Main Methods:
- Large-scale proteomic analysis of Candida albicans.
- Investigating cell wall composition and dynamics.
- Studying drug responses and mutant phenotypes.
- Monitoring serological responses to candidiasis.
- Screening for virulence factors using patient sera.
Main Results:
- Proteomics enables detailed analysis of C. albicans cell wall.
- Drug responses and virulence-associated changes in mutants are being elucidated.
- Serological markers for systemic candidiasis are being identified.
- Virulence factors are being screened using patient-derived antibodies.
Conclusions:
- Emerging proteomics approaches offer powerful tools for C. albicans research.
- These methods are crucial for understanding host-pathogen interactions.
- Future contributions in C. albicans proteomics will significantly advance the field.